Back to Market返回行情

FONR FONAR Corporation

USHealthcare
$19.09+0.00%ClosedMarket Cap: $117.8M

As of 2026-06-05 16:00

Why FONR matters now

FONAR Corporation (FONR) is a US stock in Healthcare. The latest InvestLog snapshot shows $19.09 with +0.00% on the session and $117.8M in market capitalization; recent performance reads 1-month +1.22% and YTD +2.86%.

The latest financial table shown here is Q3 2026, with revenue of $26.5M, net income of $1.6M, and EPS of $0.24. Investors can compare that operating picture with valuation signals such as P/E 15.26 and FCF yield 3.8%.

The latest indexable market news headline is "FONAR Announces Financial Results for Fiscal 2026 Third Quarter and Nine-Month Period" from Newsfile Corp.

Additional event context on this page matters because analyst consensus is available with a median target of $—; recent insider activity includes Lehman Ronald G. filing . These signals are research inputs, not a recommendation.

Valuation

P/E (TTM)

15.26

PEG

P/B

0.66

P/S

1.12

EV/EBITDA

6.47

DCF Value

$26.81

FCF Yield

3.8%

Div Yield

0.0%

Margins & Returns

Gross Margin

40.3%

Operating Margin

9.0%

Net Margin

6.4%

ROE

3.8%

ROA

3.1%

ROIC

3.6%

Financials

PeriodRevenueNet IncomeEPS
Q3 2026$26.5M$1.6M$0.24
Q2 2026$25.5M$2.1M$0.31
Q1 2026$26.0M$2.3M$0.34
Q4 2025$27.3M$729.3K$0.11

Analyst Ratings

Consensus

Target (Consensus)

$—

Target (Median)

$—

Target Range

$— - $—

Strong Buy: 0Buy: 0Hold: 0Sell: 0Strong Sell: 0

Trading Activity

Insider Trades

Lehman Ronald G.director:
Sell2026-06-09
Chan Claudettedirector:
Sell2026-06-09
Lehman Ronald G.director
Sell2026-06-09
Lehman Ronald G.director
Sell2026-06-09
Lehman Ronald G.director
Sell2026-06-09

Company Info

Sector

Healthcare

Industry

Medical - Devices

Country

US

Exchange

Beta

0.95

FONAR Corporation, along with its affiliated entities, is primarily engaged in the research, development, manufacturing, and commercialization of magnetic resonance imaging (MRI) systems within the United States. These sophisticated scanners are instrumental in the detection and diagnosis of various human diseases. The company's operations are divided into two distinct divisions: a Medical Equipment segment and a Physician Management and Diagnostic Services segment. A flagship product is their innovative Upright MRI scanner, which offers the unique capability of imaging patients in weight-bearing postures such as standing, sitting, bending, or traditional supine positions. This allows for the observation of conditions that manifest under natural gravitational stress. Furthermore, under its Physician Management segment, FONAR provides a comprehensive suite of non-medical management and administrative support services. These encompass areas like billing and collections, professional credentialing, contract negotiation, compliance consultation, IT procurement, human resources (including hiring, training, and supervision of non-clinical staff), medical record archival, office space and equipment provision, maintenance, accounting, and assistance with regulatory adherence, as well as the formulation and execution of practice growth and marketing initiatives. FONAR maintains a significant presence in diagnostic imaging services, directly owning and operating five facilities in Florida. Additionally, it oversees the management of 39 MRI scanning centers, with 25 located in New York and 14 throughout Florida. The company strategically markets its advanced MRI technology to both independent diagnostic imaging centers and hospitals. Incorporated in 1978, FONAR Corporation is headquartered in Melville, New York.